These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. Wallace M, Pappagallo M. Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551 [Abstract] [Full Text] [Related]
4. Capsaicin 8% topical patch (Qutenza)--a review of the evidence. Jones VM, Moore KA, Peterson DM. J Pain Palliat Care Pharmacother; 2011 Jan; 25(1):32-41. PubMed ID: 21426216 [Abstract] [Full Text] [Related]
5. Capsaicin. Goswami A. J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):373-5. PubMed ID: 23216177 [Abstract] [Full Text] [Related]
6. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045 [Abstract] [Full Text] [Related]
7. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J, NGX-4010 C117 Study Group. Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403 [Abstract] [Full Text] [Related]
8. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. Webster LR, Tark M, Rauck R, Tobias JK, Vanhove GF. BMC Neurol; 2010 Oct 11; 10():92. PubMed ID: 20937130 [Abstract] [Full Text] [Related]
16. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports. Trbovich M, Yang H. Am J Phys Med Rehabil; 2015 Aug 11; 94(8):e66-72. PubMed ID: 26035723 [Abstract] [Full Text] [Related]